The Association Between Arsenic Levels and Oxidative Stress in Myocardial Infarction: A Case-Control Study

Arian Sagha1, Hamidreza Shiri2, Kobra Bahrampour Juybari3

  • 1Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran.

Cardiovascular Toxicology
|January 17, 2023
PubMed

Insights

Elevated arsenic levels are linked to increased risk of myocardial infarction (MI) by promoting oxidative stress and reducing antioxidant capacity. This finding highlights arsenic as a significant risk factor for cardiovascular disease.

Area of Science:

  • Environmental toxicology
  • Cardiovascular medicine
  • Biochemistry

Background:

  • Cardiovascular diseases (CVDs), including myocardial infarction (MI), are leading global causes of mortality, with atherosclerosis as a primary underlying pathology.
  • Heavy metal exposure, specifically arsenic (Ars), is an under-investigated risk factor for CVDs.

Purpose of the Study:

  • To evaluate serum arsenic (Ars) levels in myocardial infarction (MI) patients and healthy controls.
  • To assess the association between MI incidence, Ars levels, total antioxidant capacity (TAC), and oxidative stress.

Main Methods:

  • A case-control study involving 164 MI patients and 61 healthy individuals.
  • Patients were categorized by coronary artery block (CAB) severity (>50% and <50%) based on angiography.
  • Serum Ars, TAC, and various biochemical parameters were analyzed.

Main Results:

  • Both MI patient groups (CAB >50% and CAB <50%) exhibited significantly lower TAC and higher Ars levels compared to controls.
  • TAC was notably lower in the CAB >50% group than in the CAB <50% group.
  • Arsenic levels showed a positive correlation with coronary artery block severity and traditional risk factors (HbA1c, creatinine, lipids), and an inverse correlation with TAC and HDL-c.

Conclusions:

  • Arsenic exposure at levels ≥0.105 ppm is associated with an increased risk of MI.
  • Elevated arsenic contributes to MI pathogenesis through increased oxidative stress (OS) and decreased total antioxidant capacity (TAC).
  • Arsenic, alongside other factors like hs-CRP, TG, TC, and LDL-c, exacerbates MI severity, while HDL-c and TAC offer protective effects.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
44
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
30
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
22
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
18
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
32